FR2910318B1 - Dispersion de polyaminoacides dans une phase lipidique continue. - Google Patents

Dispersion de polyaminoacides dans une phase lipidique continue.

Info

Publication number
FR2910318B1
FR2910318B1 FR0611186A FR0611186A FR2910318B1 FR 2910318 B1 FR2910318 B1 FR 2910318B1 FR 0611186 A FR0611186 A FR 0611186A FR 0611186 A FR0611186 A FR 0611186A FR 2910318 B1 FR2910318 B1 FR 2910318B1
Authority
FR
France
Prior art keywords
polyaminoacids
dispersion
lipid phase
continuous lipid
continuous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0611186A
Other languages
English (en)
Other versions
FR2910318A1 (fr
Inventor
Gauthier Pouliquen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0611186A priority Critical patent/FR2910318B1/fr
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Priority to PCT/EP2007/064352 priority patent/WO2008074871A1/fr
Priority to EP07857971A priority patent/EP2101728A1/fr
Priority to JP2009542071A priority patent/JP2010513407A/ja
Priority to CA002670453A priority patent/CA2670453A1/fr
Priority to US12/003,095 priority patent/US20080152675A1/en
Priority to CNA2007800466480A priority patent/CN101563066A/zh
Publication of FR2910318A1 publication Critical patent/FR2910318A1/fr
Application granted granted Critical
Publication of FR2910318B1 publication Critical patent/FR2910318B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0611186A 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue. Expired - Fee Related FR2910318B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0611186A FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.
EP07857971A EP2101728A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
JP2009542071A JP2010513407A (ja) 2006-12-20 2007-12-20 連続脂質相中のポリアミノ酸の分散液
CA002670453A CA2670453A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
PCT/EP2007/064352 WO2008074871A1 (fr) 2006-12-20 2007-12-20 Dispersion de polyaminoacides dans une phase lipidique continue
US12/003,095 US20080152675A1 (en) 2006-12-20 2007-12-20 Dispersion of polyamino acids in a continuous lipid phase
CNA2007800466480A CN101563066A (zh) 2006-12-20 2007-12-20 聚氨基酸在连续脂相中的分散体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0611186A FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.

Publications (2)

Publication Number Publication Date
FR2910318A1 FR2910318A1 (fr) 2008-06-27
FR2910318B1 true FR2910318B1 (fr) 2009-07-03

Family

ID=37895994

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0611186A Expired - Fee Related FR2910318B1 (fr) 2006-12-20 2006-12-20 Dispersion de polyaminoacides dans une phase lipidique continue.

Country Status (7)

Country Link
US (1) US20080152675A1 (fr)
EP (1) EP2101728A1 (fr)
JP (1) JP2010513407A (fr)
CN (1) CN101563066A (fr)
CA (1) CA2670453A1 (fr)
FR (1) FR2910318B1 (fr)
WO (1) WO2008074871A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2892725B1 (fr) * 2005-10-31 2011-03-04 Flamel Tech Sa Acides polyglutamiques fonctionnalises par des derives de l'histidine et des groupements hydrophobes et leurs applications notamment therapeutiques
CN103215125B (zh) * 2013-04-10 2014-07-02 陕西科技大学 一种油包水纳米乳液的制备方法
CN103211281B (zh) * 2013-04-10 2015-01-28 陕西科技大学 一种抗氧化油包水微乳液的制备方法
ES2502691B1 (es) * 2013-09-25 2015-07-07 Sani-Red, S.L. Método de conservación y estabilización de proteínas, aplicable para desarrollos industriales de formulaciones de productos sanitarios, farmacéuticos y cosméticos
EA201692083A1 (ru) 2014-04-16 2017-03-31 Вейкс-Фарма Гмбх Фармацевтическая композиция для ветеринарии и ее применение
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
FR3083088B1 (fr) * 2018-06-29 2020-10-02 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
JP2021505616A (ja) 2017-12-07 2021-02-18 アドシア アミリン、アミリンアゴニスト受容体またはアミリン類似体およびコポリアミノ酸を含む注射水溶液の形態の組成物
WO2019110788A1 (fr) * 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
KR20200106892A (ko) 2017-12-07 2020-09-15 아도시아 pI가 5.8 내지 8.5인 적어도 1종의 기저 인슐린, 및 카복실산염 전하 및 소수성 라디칼을 보유하는 코-폴리아미노산을 포함하는 pH 7의 주사용 용액
EP3740195A1 (fr) 2017-12-07 2020-11-25 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
WO2019110773A1 (fr) * 2017-12-07 2019-06-13 Adocia Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes
TWI813604B (zh) * 2017-12-07 2023-09-01 法商阿道洽公司 包含至少一具有pi從5.8至8.5之基礎胰島素以及一帶有羧酸鹽電荷及疏水基之共聚胺基酸的可注射ph7溶液
JP6582084B2 (ja) * 2018-03-22 2019-09-25 ライオン株式会社 口腔用組成物
CN111603441B (zh) * 2020-07-01 2022-11-25 瑞希(重庆)生物科技有限公司 一种两亲性聚氨基酸共聚物/泊洛沙姆温敏凝胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06128149A (ja) * 1992-09-04 1994-05-10 Japan Tobacco Inc 水溶性物質を含有してなるw/o型エマルジョン及び油剤
FR2702373B1 (fr) * 1993-03-08 1996-06-07 Rhone Merieux Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable.
FR2732218B1 (fr) * 1995-03-28 1997-08-01 Flamel Tech Sa Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
MXPA03007766A (es) * 2001-02-28 2004-03-16 Akzo Nobel Nv Emulsiones inyectables de agua en aceite.
FR2840614B1 (fr) * 2002-06-07 2004-08-27 Flamel Tech Sa Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
EP1731139A4 (fr) * 2004-03-31 2008-12-03 Aspion Co Ltd Preparation pharmaceutique de type s/o et procede de production associe

Also Published As

Publication number Publication date
EP2101728A1 (fr) 2009-09-23
US20080152675A1 (en) 2008-06-26
CN101563066A (zh) 2009-10-21
WO2008074871A1 (fr) 2008-06-26
CA2670453A1 (fr) 2008-06-26
JP2010513407A (ja) 2010-04-30
FR2910318A1 (fr) 2008-06-27

Similar Documents

Publication Publication Date Title
FR2910318B1 (fr) Dispersion de polyaminoacides dans une phase lipidique continue.
DE602007013341D1 (de) Phasenwechseltinten
DE602006011058D1 (de) Kontinuierliches backup
DE602008001460D1 (de) Flüssigkristallanzeige
DE602007010066D1 (de) Flüssigkristallanzeige
DK2122344T3 (da) Lipiddobbeltlags-sensorsystem
FR2925118B1 (fr) Panneau de support d'abradable dans une turbomachine
DE602007006531D1 (de) Pyrazin-2-carboxamid-derivate als cb2-rezeptormodulatoren
BRPI0811551A2 (pt) Articulação de quatro pontos
EP2126821A4 (fr) Facteurs d'incitation au partage du marché
EP2201025A4 (fr) Produits de construction lipidiques fonctionnels
DE602007004038D1 (de) Flüssigkristallanzeige
BRPI0815376A2 (pt) Dextrose diretamente compresível
BRPI0906881A2 (pt) Articulação de direção
FR2933126B1 (fr) Actionnement d'un inverseur de poussee dans une turbomachine
DE602008000227D1 (de) Flüssigkristallanzeige
FR2913480B1 (fr) Joint tournant
AU2007209465A8 (en) Acyclic sulfamide derivatives
FR2896760B1 (fr) Bequille de velo
DE602008003594D1 (de) Phasenwechseltinte
FR2939257B1 (fr) Interpolateur de phase
DE602007011413D1 (de) Phasenregelkreiselement
FR2901203B1 (fr) Ensemble de recouvrement des bagages comprenant une structure mediane
FR2907486B3 (fr) Cheville pour une charniere.
FR2906141B1 (fr) Structure uni-ou multivesciculaire enfermant une phase hydrophobe.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829